What are Analysts opinions on Forum Energy Technologies, Inc.(NYSE:FET): Adamis Pharmaceuticals Corporation(NASDAQ:ADMP)

0
4

Forum Energy Technologies, Inc. (FET) will report its next earnings on Oct 29 AMC. The company reported the earnings of $0.03/Share in the last quarter where the estimated EPS by analysts was $0.02/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 50%.

Many analysts are providing their Estimated Earnings analysis for Forum Energy Technologies, Inc. and for the current quarter 13 analysts have projected that the stock could give an Average Earnings estimate of $-0.03/share. These analysts have also projected a Low Estimate of $-0.05/share and a High Estimate of $0.03/share.

In case of Revenue Estimates, 10 analysts have provided their consensus Average Revenue Estimates for Forum Energy Technologies, Inc. as 264.14 Million. According to these analysts, the Low Revenue Estimate for Forum Energy Technologies, Inc. is 249 Million and the High Revenue Estimate is 296 Million. The company had Year Ago Sales of 247.7 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for FET to be 50%. They are projecting Next Quarter growth of 100%. For the next 5 years, Forum Energy Technologies, Inc. is expecting Growth of 272.77% per annum, whereas in the past 5 years the growth was 78.95% per annum.

Some buy side analysts are also providing their Analysis on Forum Energy Technologies, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Forum Energy Technologies, Inc. might touch $15 high while the Average Price Target and Low price Target is $10.96 and $7 respectively.

Forum Energy Technologies, Inc. closed its last trading session at $6.19 with the gain of 0%. The Market Capitalization of the company stands at 702.01 Million. The Company has 52-week high of $17.95 and 52-week low of $6.13. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -16.33% where SMA50 and SMA200 are -29.66% and -45.85% respectively. The Company Touched its 52-Week High on 01/24/18 and 52-Week Low on 12/04/18.

The Relative Volume of the company is 1.76 and Average Volume (3 months) is 1.13 million. The company’s P/E (price to earnings) ratio is 12.4 and Forward P/E ratio of 32.41.

The company shows its Return on Assets (ROA) value of 2.7%. The Return on Equity (ROE) value stands at 4.1%. While it’s Return on Investment (ROI) value is -0.8%.

While looking at the Stock’s Performance, Forum Energy Technologies, Inc. currently shows a Weekly Performance of -14.5%, where Monthly Performance is -29.5%, Quarterly performance is -45.22%, 6 Months performance is -54.49% and yearly performance percentage is -59.54%. Year to Date performance value (YTD perf) value is -60.19%. The Stock currently has a Weekly Volatility of 6.61% and Monthly Volatility of 5.98%.

Adamis Pharmaceuticals Corporation (ADMP) will report its next earnings on Nov 23. The company reported the earnings of $-0.21/Share in the last quarter where the estimated EPS by analysts was $-0.17/share. The difference between the expected and actual EPS was $-0.04/share, which represents an Earnings surprise of -23.5%.

Many analysts are providing their Estimated Earnings analysis for Adamis Pharmaceuticals Corporation and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for Adamis Pharmaceuticals Corporation as 5.67 Million. According to these analysts, the Low Revenue Estimate for Adamis Pharmaceuticals Corporation is 4.24 Million and the High Revenue Estimate is 7.4 Million. The company had Year Ago Sales of 2.84 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for ADMP to be 37.5%. They are projecting Next Quarter growth of 47.83%. For the next 5 years, Adamis Pharmaceuticals Corporation is expecting Growth of 52.33% per annum, whereas in the past 5 years the growth was 4.44% per annum.

Some buy side analysts are also providing their Analysis on Adamis Pharmaceuticals Corporation, where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Adamis Pharmaceuticals Corporation might touch $10 high while the Average Price Target and Low price Target is $7 and $2.5 respectively.

Adamis Pharmaceuticals Corporation closed its last trading session at $2.83 with the gain of 0%. The Market Capitalization of the company stands at 121.55 Million. The Company has 52-week high of $5.10 and 52-week low of $2.20. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.78% where SMA50 and SMA200 are -2.42% and -16.93% respectively. The Company Touched its 52-Week High on 07/02/18 and 52-Week Low on 08/21/18.

The Relative Volume of the company is 0.37 and Average Volume (3 months) is 688.7 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -66.8%. The Return on Equity (ROE) value stands at -87.6%. While it’s Return on Investment (ROI) value is -33.7%.

While looking at the Stock’s Performance, Adamis Pharmaceuticals Corporation currently shows a Weekly Performance of 6.79%, where Monthly Performance is 3.66%, Quarterly performance is -0.7%, 6 Months performance is -29.25% and yearly performance percentage is -29.25%. Year to Date performance value (YTD perf) value is -35.68%. The Stock currently has a Weekly Volatility of 8.31% and Monthly Volatility of 7.49%.

SHARE